Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients

Classification of patients with rheumatoid arthritis (RA) as quickly as possible improves their prognosis. This reason motivates specially dedicated early arthritis (EA) clinics. Here, we have used 1062 EA patients with two years of follow-up to explore the value of anti-carbamylated protein (anti-C...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Sci Rep
Autores principales: Regueiro, Cristina, Nuño, Laura, Ortiz, Ana M., Peiteado, Diana, Villalba, Alejandro, Pascual-Salcedo, Dora, Martínez-Feito, Ana, González-Alvaro, Isidoro, Balsa, Alejandro, González, Antonio
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5607236/
https://ncbi.nlm.nih.gov/pubmed/28931886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-09657-5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares